Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical BMT with PTCy for Pediatric Hematologic Malignancies
NCT02120157Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jul 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cyclophosphamide in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), juvenile myelomonocytic leukemia (JMML), mixed phenotype acute leukemia (MPAL), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jul 2015; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)juvenile myelomonocytic leukemia (JMML)mixed phenotype acute leukemia (MPAL)
Beyond the preview
Go deeper on NCT02120157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120157.